Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3
Published April 12, 2023 · Recall initiated: March 23, 2023
Summary
FDA records drug Class II recall D-0520-2023, published April 12, 2023 and initiated March 23, 2023. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 264 Bottles; Lot: Lot: A1723C, Exp 8/31/2025; Lot: A1922B, Exp 6/30/2024; Lot: D0622M and Lot: F2922I, Exp 7/31/2024; Lot: G3021L, Exp 1/31/2024; Lot:H2622P & Lot: J0722C, Exp 10/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot: A1723C, Exp 8/31/2025; Lot: A1922B, Exp 6/30/2024; Lot: D0622M and Lot: F2922I, Exp 7/31/2024; Lot: G3021L, Exp 1/31/2024; Lot:H2622P & Lot: J0722C, Exp 10/31/2024.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAArtificial Tears Lubricant Eye Drops, Visine, Pkg Size: 15, Mfg: Geri-Care: Brooklyn, NY. NDC: 68788-7266-0November 11, 2026
- FDALidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro PharmaceuticalsOctober 14, 2026
- FDAArtificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 ozApril 15, 2026
- FDAOndansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged byDecember 24, 2025
- FDARosuvastatin Tablets, USP, 10 mg, Packaged as: a) 30-count bottle (NDC 68788-7086-3); b) 90-count bottle (NDCApril 12, 2023
- FDAPravastatin Sodium Tablets, USP, 20 mg, 90-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc.,April 12, 2023
Questions about this recall
Was Rosuvastatin Tablets, USP, 5mg, 30-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7971-3 recalled?
Yes. FDA published recall D-0520-2023 on April 12, 2023. Reported hazard: cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Letter